BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24929344)

  • 1. Synthesis and identification of cytotoxic diphyllin glycosides as vacuolar H(+)-ATPase inhibitors.
    Zhang Z; Ma J; Zhu L; Zhao Y
    Eur J Med Chem; 2014 Jul; 82():466-71. PubMed ID: 24929344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of Cleistanthin A Derivatives as Potent Vacuolar H(+) -ATPase Inhibitors.
    Zhao Y; Lu Y; Ma J; Zhu L
    Chem Biol Drug Des; 2015 Oct; 86(4):691-6. PubMed ID: 25677205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and bioevaluation of heterocyclic derivatives of Cleistanthin-A.
    Zhao Y; Zhang R; Lu Y; Ma J; Zhu L
    Bioorg Med Chem; 2015 Aug; 23(15):4884-4890. PubMed ID: 26059594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel lignan glycosides as anticancer agents.
    Wang Y; Xia C; Zhang W; Zhao Y
    Chem Biol Drug Des; 2016 Oct; 88(4):562-7. PubMed ID: 27160642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and bioevaluation of diphyllin glycosides as novel anticancer agents.
    Zhao Y; Ni C; Zhang Y; Zhu L
    Arch Pharm (Weinheim); 2012 Aug; 345(8):622-8. PubMed ID: 22592997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2, 4, 5-Trideoxyhexopyranosides derivatives of diphyllin: Synthesis and anticancer activity.
    Cai R; Li Y; Zhu L; Wei C; Bao X; Zhao Y
    Chem Biol Drug Des; 2022 Aug; 100(2):256-266. PubMed ID: 35614538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZT-25, a new vacuolar H(+)-ATPase inhibitor, induces apoptosis and protective autophagy through ROS generation in HepG2 cells.
    Lu Y; Zhang R; Liu S; Zhao Y; Gao J; Zhu L
    Eur J Pharmacol; 2016 Jan; 771():130-8. PubMed ID: 26689625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of indirubin-N'-glycosides and their anti-proliferative activity against human cancer cell lines.
    Libnow S; Methling K; Hein M; Michalik D; Harms M; Wende K; Flemming A; Köckerling M; Reinke H; Bednarski PJ; Lalk M; Langer P
    Bioorg Med Chem; 2008 May; 16(10):5570-83. PubMed ID: 18434163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
    Sørensen MG; Henriksen K; Neutzsky-Wulff AV; Dziegiel MH; Karsdal MA
    J Bone Miner Res; 2007 Oct; 22(10):1640-8. PubMed ID: 17576165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, cytotoxicity and anti-invasion activity of three natural diphyllin L-arabinopyranosides.
    Cai R; Zhu L; Shen W; Zhao Y
    Fitoterapia; 2019 Sep; 137():104198. PubMed ID: 31175951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
    Buscató E; Büttner D; Brüggerhoff A; Klingler FM; Weber J; Scholz B; Zivković A; Marschalek R; Stark H; Steinhilber D; Bode HB; Proschak E
    ChemMedChem; 2013 Jun; 8(6):919-23. PubMed ID: 23596124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
    Niikura K; Takano M; Sawada M
    Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological effects of a new vacuolar-H,-ATPase inhibitor in colon carcinoma cell lines.
    Supino R; Scovassi AI; Croce AC; Dal Bo L; Favini E; Corbelli A; Farina C; Misiano P; Zunino F
    Ann N Y Acad Sci; 2009 Aug; 1171():606-16. PubMed ID: 19723111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of genotoxic and anti-mutagenic properties of cleistanthin A and cleistanthoside A tetraacetate.
    Himakoun L; Tuchinda P; Puchadapirom P; Tammasakchai R; Leardkamolkarn V
    Asian Pac J Cancer Prev; 2011; 12(12):3271-5. PubMed ID: 22471465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. V-ATPase as an effective therapeutic target for sarcomas.
    Perut F; Avnet S; Fotia C; Baglìo SR; Salerno M; Hosogi S; Kusuzaki K; Baldini N
    Exp Cell Res; 2014 Jan; 320(1):21-32. PubMed ID: 24416789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral efficacy of nanoparticulate vacuolar ATPase inhibitors against influenza virus infection.
    Hu CJ; Chen YT; Fang ZS; Chang WS; Chen HW
    Int J Nanomedicine; 2018; 13():8579-8593. PubMed ID: 30587980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Cytotoxicity, Anti-Migration and Anti-Invasion Activity of Diphyllin Heterocyclic Derivatives.
    Shen W; Chen H; Wu M; Zhang T; Zhu L; Zhao Y
    Med Chem; 2022; 18(1):122-129. PubMed ID: 33349219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic Prioritization of Diphyllin Derivatives That Block Filoviral Cell Entry by Vacuolar (H
    Lindstrom A; Anantpadma M; Baker L; Raghavendra NM; Davey R; Davisson VJ
    ChemMedChem; 2018 Dec; 13(24):2664-2676. PubMed ID: 30335906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of diphyllin as a novel V-ATPase inhibitor on gastric adenocarcinoma.
    Shen W; Zou X; Chen M; Liu P; Shen Y; Huang S; Guo H; Zhang L
    Eur J Pharmacol; 2011 Sep; 667(1-3):330-8. PubMed ID: 21645513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and cytotoxic activity evaluation of new aminosubstituted benzofurans.
    Daniilides K; Lougiakis N; Pouli N; Marakos P; Samara P; Tsitsilonis O
    Med Chem; 2014; 10(6):619-27. PubMed ID: 24047215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.